Milo Puhan

Milo Puhan

Universität Zürich

H-index: 91

Europe-Switzerland

About Milo Puhan

Milo Puhan, With an exceptional h-index of 91 and a recent h-index of 68 (since 2020), a distinguished researcher at Universität Zürich, specializes in the field of Epidemiologic methods, chronic diseases, multimorbidity, prevention, benefit harm assessment.

His recent articles reflect a diverse array of research interests and contributions to the field:

Swiss chiropractic cohort (Swiss ChiCo) pilot study: feasibility for a musculoskeletal cohort study conducted within a nationwide practice-based research network

Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post–COVID-19 Syndrome

A guide for a student-led doctoral-level qualitative methods short course in epidemiology: faculty and student perspectives

Lung Cancer in Switzerland

What gets measured gets managed: A scoping review of musculoskeletal research conducted within practice-based research networks

Global benchmarks in primary robotic bariatric surgery redefine quality standards for Roux-en-Y gastric bypass and sleeve gastrectomy

Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter

A New Model for Ranking Schools of Public Health: The Public Health Academic Ranking

Milo Puhan Information

University

Universität Zürich

Position

Professor of Epidemiology & Public Health

Citations(all)

42135

Citations(since 2020)

24605

Cited By

26526

hIndex(all)

91

hIndex(since 2020)

68

i10Index(all)

318

i10Index(since 2020)

276

Email

University Profile Page

Universität Zürich

Milo Puhan Skills & Research Interests

Epidemiologic methods

chronic diseases

multimorbidity

prevention

benefit harm assessment

Top articles of Milo Puhan

Swiss chiropractic cohort (Swiss ChiCo) pilot study: feasibility for a musculoskeletal cohort study conducted within a nationwide practice-based research network

Authors

Rahim Lalji,Léonie Hofstetter,Alice Kongsted,Viktor von Wyl,Julia Braun,Milo A Puhan,Cesar A Hincapié

Journal

European Spine Journal

Published Date

2024/3/13

PurposePractice-based research networks are collaborations between clinicians and researchers to advance primary care research. This study aims to assess the feasibility for longitudinal data collection within a newly established chiropractic PBRN in Switzerland.MethodsA prospective observational cohort feasibility study was performed. PBRN participating chiropractors were asked to recruit patients seeking new conservative health care for musculoskeletal pain from March 28, 2022, to September 28, 2022. Participants completed clinically oriented survey questions and patient-reported outcome measures before the initial chiropractic assessment as well as 1 h, 2 weeks, 6 weeks, and 12 weeks thereafter. Feasibility was assessed through a variety of process, resource, and management metrics. Patient clinical outcomes were also assessed.ResultsA total of 76 clinicians from 35 unique primary care chiropractic …

Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post–COVID-19 Syndrome

Authors

Martin Achleitner,Nina K Mair,Juliane Dänhardt,Romina Kardashi,Milo A Puhan,Irene A Abela,Nicole Toepfner,Katja de With,Waldemar Kanczkowski,Natalia Jarzebska,Roman N Rodionov,Christine Wolf,Min Ae Lee-Kirsch,Charlotte Steenblock,Benjamin G Hale,Stefan R Bornstein

Journal

Open Forum Infectious Diseases

Published Date

2024/1

Genetic defects in the interferon (IFN) system or neutralizing autoantibodies against type I IFNs contribute to severe COVID-19. Such autoantibodies were proposed to affect post–COVID-19 syndrome (PCS), possibly causing persistent fatigue for >12 weeks after confirmed SARS-CoV-2 infection. In the current study, we investigated 128 patients with PCS, 21 survivors of severe COVID-19, and 38 individuals who were asymptomatic. We checked for autoantibodies against IFN-α, IFN-β, and IFN-ω. Few patients with PCS had autoantibodies against IFNs but with no neutralizing activity, indicating a limited role of type I IFNs in PCS pathogenesis. In a subset consisting of 28 patients with PCS, we evaluated IFN-stimulated gene activity and showed that it did not correlate with fatigue. In conclusion, impairment of the type I IFN system is unlikely responsible for adult PCS.

A guide for a student-led doctoral-level qualitative methods short course in epidemiology: faculty and student perspectives

Authors

Felix Gille,Anja Frei,Marco Kaufmann,Anja Lehmann,Javier Muñoz Laguna,Kimon Papadopoulos,Angela Spörri,Mina Stanikić,Martin Tušl,Federica Zavattaro,Milo Alan Puhan

Journal

International Journal of Epidemiology

Published Date

2024/4/1

Qualitative research and mixed methods are core competencies for epidemiologists. In response to the shortage of guidance on graduate course development, we wrote a course development guide aimed at faculty and students designing similar courses in epidemiology curricula. The guide combines established educational theory with faculty and student experiences from a recent introductory course for epidemiology and biostatistics doctoral students at the University of Zurich and Swiss Federal Institute of Technology, Zurich. We propose a student-centred course with inverse classroom teaching and practice exercises with faculty input. Integration of student input during the course development process helps align the course syllabus with student needs. The proposed course comprises six sessions that cover learning outcomes in comprehension, knowledge, application, analysis, synthesis and evaluation …

Lung Cancer in Switzerland

Authors

Raphael Sven Werner,Alessandra Curioni-Fontecedro,Laetitia A Mauti,Alfredo Addeo,Solange Peters,Thomas Frauenfelder,Milo A Puhan,Martina Haberecker,Lukas Bubendorf,Tobias Finazzi,Matthias Guckenberger,Stefano Cafarotti,Thomas Geiser,Isabelle Opitz

Published Date

2024/3/1

Currently, 8.7 million people live in Switzerland—a number that has more than doubled in the past 100 years. In the same time, the population has become significantly older, and today, one-fifth is beyond retirement age (65 y in Switzerland). With an average life expectancy of 82 years in men and 86 years in women, Switzerland has one of the highest life expectancies worldwide. 1 Annually, 43,000 people are diagnosed with having cancer in Switzerland. The estimated age-standardized lung cancer incidence in Switzerland is lower than that in surrounding countries (Fig. 1). Comparable to international data, lung cancer is the third most prevalent cancer entity in Switzerland and the most common cause of cancer death. 2One of the distinctive features of the Swiss medical system is the principle of a mandatory health insurance for all residents but one that is provided solely through private health insurance …

What gets measured gets managed: A scoping review of musculoskeletal research conducted within practice-based research networks

Authors

Rahim Lalji,Javier Muñoz Laguna,Jael Kauth,Léonie Hofstetter,Astrid Kurmann,Jon Adams,Alice Kongsted,Viktor von Wyl,Milo A Puhan,Cesar A Hincapié

Published Date

2024/4/16

Musculoskeletal (MSK) conditions are often managed in primary care settings. To facilitate research and health care quality, practice-based research networks (PBRNs) offer sustained collaborations between clinicians and researchers. A scoping review was conducted to describe characteristics of PBRNs used for MSK research and MSK research conducted through PBRNs. PBRNs were identified from 1) MSK-studies identified In OVID Medline, CINAHL, and Embase databases from inception to 05 February 2023 and in ClinicalTrials. gov; and 2) from PBRN registries and websites. Among active MSK-focused PBRNs (ie, currently recruiting and conducting research), an assessment of PBRN research good practices was performed. After screening 3025 records, 85 studies from 46 unique PBRNs met our eligibility criteria. Common conditions studied were low back pain (28%), MSK conditions not otherwise …

Global benchmarks in primary robotic bariatric surgery redefine quality standards for Roux-en-Y gastric bypass and sleeve gastrectomy

Authors

Guillaume Giudicelli,Daniel Gero,Lind Romulo,Vasu Chirumamilla,Pouya Iranmanesh,Christopher K Owen,Wayne Bauerle,Amador Garcia,Lisa Lucas,Anne-Sophie Mehdorn,Dhananjay Pandey,Abdullah Almuttawa,Francisco Cabral,Abhishek Tiwari,Virginia Lambert,Beniamino Pascotto,Celine De Meyere,Marouan Yahyaoui,Thomas Haist,Oliver Scheffel,Maud Robert,Frederiek Nuytens,Santiago Azagra,Lilian Kow,Arun Prasad,Carlos Vaz,Michel Vix,Vivek Bindal,Jan H Beckmann,David Soussi,Ramon Vilallonga,Maher El Chaar,Erik B Wilson,Arif Ahmad,Andre Teixeira,Monika E Hagen,Christian Toso,Pierre-Alain Clavien,Milo Puhan,Marco Bueter,Minoa K Jung

Journal

British Journal of Surgery

Published Date

2024/1

Background Whether the benefits of the robotic platform in bariatric surgery translate into superior surgical outcomes remains unclear. The aim of this retrospective study was to establish the ‘best possible’ outcomes for robotic bariatric surgery and compare them with the established laparoscopic benchmarks. Methods Benchmark cut-offs were established for consecutive primary robotic bariatric surgery patients of 17 centres across four continents (13 expert centres and 4 learning phase centres) using the 75th percentile of the median outcome values until 90 days after surgery. The benchmark patients had no previous laparotomy, diabetes, sleep apnoea, cardiopathy, renal insufficiency, inflammatory bowel disease, immunosuppression, history of thromboembolic events, BMI greater than 50 kg/m2, or age greater than 65 years. Results A total of 9097 …

Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter

Authors

N Probst-Hensch,M Imboden,A Jeong,D Keidel,T Vermes,M Witzig,S Cullati,S Tancredi,N Noor,P-Y Rodondi,E Harju,G Michel,I Frank,C Kahlert,A Cusini,Nicolas Rodondi,Patricia Orializ Chocano-Bedoya,Julia Bianca Bardoczi,Mirah Julia Stuber,F Vollrath,J Fehr,A Frei,M Kaufmann,M Geigges,V von Wyl,MA Puhan,E Albanese,L Crivelli,GF Lovison,Corona Immunitas Research Group

Journal

Comprehensive psychiatry

Published Date

2024/4/1

Previous mental health trajectory studies were mostly limited to the months before access to vaccination. They are not informing on whether public mental health has adapted to the pandemic. The aim of this analysis was to 1) investigate trajectories of monthly reported depressive symptoms from July 2020 to December 2021 in Switzerland, 2) compare average growth trajectories across regions with different stringency phases, and 3) explore the relative impact of self-reported worries related to health, economic and social domains as well as socio-economic indicators on growth trajectories. As part of the population-based Corona Immunitas program of regional, but harmonized, adult cohorts studying the pandemic course and impact, participants repeatedly reported online to the DASS-21 instrument on depressive symptomatology. Trajectories of depressive symptoms were estimated using a latent growth model …

A New Model for Ranking Schools of Public Health: The Public Health Academic Ranking

Authors

Adeline Dugerdil,Awa Babington-Ashaye,Murielle Bochud,Margaret Chan,Arnaud Chiolero,Andreas Gerber-Grote,Nino Künzli,Gilles Paradis,Milo Alan Puhan,L Suzanne Suggs,Klazine Van der Horst,Gérard Escher,Antoine Flahault

Journal

International journal of public health

Published Date

2024/3/11

Objectives: As there is no ranking designed for schools of Public Health, the aim of this project was to create one.Methods: To design the Public Health Academic Ranking (PHAR), we used the InCites Benchmarking and Analytics™ software and the Web Of Science™ Core Collection database. We collected bibliometric data on 26 schools of Public Health from each continent, between August and September 2022. We included 11 research indicators/scores, covering four criteria (productivity, quality, accessibility for readers, international collaboration), for the period 2017–2021. For the Swiss School of Public Health (SSPH+), a network gathering faculties across different universities, a specific methodology was used, with member-specific research queries.Results: The five top schools of the PHAR were: London School of Hygiene and Tropical Medicine, Public Health Foundation of India, Harvard T.H. Chan School of Public Health, SSPH+, Johns Hopkins Bloomberg School of Public Health.Conclusion: The PHAR allows worldwide bibliometric ordering of schools of Public Health. As this is a pilot project, the results must be taken with caution. This article aims to critically discuss its methodology and future improvements.

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid

Authors

Carlo Cervia-Hasler,Sarah C Brüningk,Tobias Hoch,Bowen Fan,Giulia Muzio,Ryan C Thompson,Laura Ceglarek,Roman Meledin,Patrick Westermann,Marc Emmenegger,Patrick Taeschler,Yves Zurbuchen,Michele Pons,Dominik Menges,Tala Ballouz,Sara Cervia-Hasler,Sarah Adamo,Miriam Merad,Alexander W Charney,Milo Puhan,Petter Brodin,Jakob Nilsson,Adriano Aguzzi,Miro E Raeber,Christoph B Messner,Noam D Beckmann,Karsten Borgwardt,Onur Boyman

Journal

Science

Published Date

2024/1/19

Long Covid is a debilitating condition of unknown etiology. We performed multimodal proteomics analyses of blood serum from COVID-19 patients followed up to 12 months after confirmed severe acute respiratory syndrome coronavirus 2 infection. Analysis of >6500 proteins in 268 longitudinal samples revealed dysregulated activation of the complement system, an innate immune protection and homeostasis mechanism, in individuals experiencing Long Covid. Thus, active Long Covid was characterized by terminal complement system dysregulation and ongoing activation of the alternative and classical complement pathways, the latter associated with increased antibody titers against several herpesviruses possibly stimulating this pathway. Moreover, markers of hemolysis, tissue injury, platelet activation, and monocyte–platelet aggregates were increased in Long Covid. Machine learning confirmed complement …

An Unwanted but Long-Known Company: Post-Viral Symptoms in the Context of Past Pandemics in Switzerland (and Beyond)

Authors

Kaspar Staub,Tala Ballouz,Milo Puhan

Published Date

2024/4/8

Objectives: Some people do not fully recover from an acute viral infection and experience persistent symptoms or incomplete recovery for months or even years. This is not unique to the SARS-CoV-2 virus and history shows that post-viral conditions like post COVID-19 condition, also referred to as Long Covid, are not new. In particular, during and after pandemics caused by respiratory viruses in which large parts of the population were infected or exposed, professional and public attention was increased, not least because of the large number of people affected.Methods: Given the current relevance of the topic, this article aims to narratively review and summarize the literature on post-viral symptoms during past pandemics and to supplement and illustrate it with Swiss examples from the pandemics of 1890, 1918–1920 and later.Results: Post-viral diseases were an increasingly emphasised health topic during and after past pandemics triggered by respiratory infections over the last 150 years.Conclusion: In the next pandemic, it should not be surprising that post-viral conditions will again play a role, and pandemic plans should reflect this.

Surgical Outcome Reporting. Moving from a Comic to a Tragic Opera?

Authors

Fariba Abbassi,Matthias Pfister,Anja Domenghino,Milo A Puhan,Pierre-Alain Clavien

Journal

Annals of Surgery

Published Date

2024/2/7

Objectives:To assess the current quality of surgical outcome reporting in the medical literature, and to provide recommendations for improvement.Background:In 1996, the Lancet labelled surgery as a “comic opera” mostly referring to the poor quality of outcome reporting in the literature impeding improvement in surgical quality and patient care.Methods:We screened three 1 st tier and two 2 nd tier surgical journals, as well as three leading medical journals for original articles reporting on results of surgical procedures published over a recent 18-month period. The quality of outcome reporting was assessed using a pre-specified 12-item checklist.Results:627 articles reporting surgical outcomes were analyzed, including 125 randomized controlled trials (RCT). Only 1 (0· 2%) article met all 12 criteria of the checklist, while 356 articles (57%) fulfilled less than half of criteria. The poorest reporting was on cumulative …

Benefit-Harm Analysis for Informed Decision Making on Participating in Colorectal Cancer Screening: A Modeling Study

Authors

Henock G Yebyo,Francine van Wifferen,Linda PM Pluymen,Mariska MG Leeflang,Evelien Dekker,Veerle MH Coupé,Milo A Puhan,Marjolein JE Greuter,Inge Stegeman

Journal

Value in Health

Published Date

2024/4/1

ObjectivesTo facilitate informed decision making on participating in colorectal cancer (CRC) screening, we assessed the benefit-harm balance of CRC screening for a wide range of subgroups over different time horizons.MethodsThe study combined incidence proportions of benefits and harms of (not) participating in CRC screening estimated by the Adenoma and Serrated pathway to CAncer microsimulation model, a preference eliciting survey, and benefit-harm balance modeling combining all outcomes to determine the net health benefit of CRC screening over 10, 20, and 30 years. Probability of net health benefit was estimated for 210 different subgroups based on age, sex, previous participation in CRC screening, and lifestyle.ResultsCRC screening was net beneficial in 183 of 210 subgroups over 30 years (median probability [MP] of 0.79, interquartile range [IQR] of 0.69-0.85) across subgroups. Net health …

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

Authors

Irene A Abela,Magdalena Schwarzmüller,Agne Ulyte,Thomas Radtke,Sarah R Haile,Priska Ammann,Alessia Raineri,Sonja Rueegg,Selina Epp,Christoph Berger,Jürg Böni,Amapola Manrique,Annette Audigé,Michael Huber,Peter W Schreiber,Thomas Scheier,Jan Fehr,Jacqueline Weber,Peter Rusert,Huldrych F Günthard,Roger D Kouyos,Milo A Puhan,Susi Kriemler,Alexandra Trkola,Chloé Pasin

Journal

Mbio

Published Date

2024/2/14

Numerous clinical parameters link to severe coronavirus disease 2019, but factors that prevent symptomatic disease remain unknown. We investigated the impact of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and endemic human coronavirus (HCoV) antibody responses on symptoms in a longitudinal children cohort (n = 2,917) and a cross-sectional cohort including children and adults (n = 882), all first exposed to SARS-CoV-2 (March 2020 to March 2021) in Switzerland. Saliva (n = 4,993) and plasma (n = 7,486) antibody reactivity to the four HCoVs (subunit S1 [S1]) and SARS-CoV-2 (S1, receptor binding domain, subunit S2 [S2], nucleocapsid protein) was determined along with neutralizing activity against SARS-CoV-2 Wuhan, Alpha, Delta, and Omicron (BA.2) in a subset of individuals. Inferred recent SARS-CoV-2 infection was associated with a strong correlation between mucosal and …

Outcomes in studies regarding older patients with prostate cancer: A systematic review

Authors

Kim FT Jochems,Dominik Menges,Dafne Sanchez,Nienke A de Glas,Hans Wildiers,Daniel Eberli,Milo A Puhan,Esther Bastiaannet

Published Date

2024/4/4

IntroductionOlder patients are often deemed ineligible for clinical research, and many frequently-used endpoints and outcome measures are not as relevant for older patients for younger ones. This systematic review aimed to present an overview of outcomes used in clinical research regarding patients over the age of 65 years with prostate cancer.Materials and MethodsPubMed and Embase were systematically searched to identify studies on prostate cancer (treatment) in patients aged ≥65 between 2016 and 2023. Data on title, study design, number of participants and age, stage of disease, treatment, and investigated outcomes were synthesized and descriptively analyzed.ResultsSixty-eight studies were included. Of these most included patients over 65 years, while others used a higher age. Overall, 39 articles (57.3%) reported on survival-related outcomes, 22 (32.4%) reported on progression of disease and 38 …

Abnormal exertional breathlessness on cardiopulmonary cycle exercise testing in relation to self-reported and physiological responses in chronic airflow limitation

Authors

Magnus Ekström,Pei Zhi Li,Hayley Lewthwaite,Jean Bourbeau,Wan C Tan,Dennis Jensen,J Mark FitzGerald,Don D Sin,Darcy D Marciniuk,Denis E O’Donnell,Paul Hernandez,Kenneth R Chapman,Brandie Walker,Shawn Aaron,François Maltais,Jonathon Samet,Milo Puhan,Qutayba Hamid,James C Hogg,Dany Doiron,Palmina Mancino,Carolyn Baglole,Yvan Fortier,Don Sin,Julia Yang,Jeremy Road,Joe Comeau,Adrian Png,Kyle Johnson,Harvey Coxson,Jonathon Leipsic,Cameron Hague,Miranda Kirby,Mohsen Sadatsafavi,Teresa To,Andrea Gershon,Pei-Zhi Li,Zhi Song,Andrea Benedetti,Christine Lo,Sarah Cheng,Elena Un,Cynthia Fung,Wen Tiang Wang,Liyun Zheng,Faize Faroon,Olga Radivojevic,Sally Chung,Carl Zou,Jacinthe Baril,Laura Labonte,Kenneth Chapman,Patricia McClean,Nadeen Audisho,Curtis Dumonceaux,Lisette Machado,Scott Fulton,Kristen Osterling,Denise Wigerius,Kathy Vandemheen,Gay Pratt,Amanda Bergeron,Denis O’Donnell,Matthew McNeil,Kate Whelan,Cynthia Brouillard,Darcy Marciniuk,Ron Clemens,Janet Baran,Candice Leuschen

Journal

Chest

Published Date

2024/2/27

Background Exertional breathlessness is a cardinal symptom of cardiorespiratory disease. Research Question How does breathlessness abnormality, graded using normative reference equations during cardiopulmonary exercise testing (CPET), relate to self-reported and physiological responses in people with chronic airflow limitation (CAL)? Study Design and Methods An analysis was done of people aged≥ 40 years with CAL undergoing CPET in the Canadian Cohort Obstructive Lung Disease study. Breathlessness intensity ratings (Borg CR10 scale [0-10 category-ratio scale for breathlessness intensity rating]) were evaluated in relation to power output (W), rate of oxygen uptake (V˙ o 2), and minute ventilation (V˙ e) at peak exercise, using normative reference equations as follows:(1) probability of breathlessness normality (probability of having an equal or greater Borg CR10 rating among healthy; lower …

Is Statistical Significance Alone Obsolete?–Let’s Turn to Meaningful Interpretation of Scientific and Real-world Evidence on Surgical Care

Authors

Milo A Puhan,Pierre-Alain Clavien

Journal

Annals of Surgery

Published Date

2024/3/20

The recent consensus conference Outcome4Medicine highlighted the need for broad outcome assessment after surgery to include the perspective of multiple stakeholders (1), which is currently severely lacking in the medical literature (2). Many parameters measured in clinical practice and research reflect primarily the physicians’ perspective and are interpreted by some arbitrary thresholds for statistical significance (p≤ 0.05). This is not sufficient and can be highly misleading. Patients and their families, nurses, allied health professionals, payers, policymakers, and the public also need scientific and real-world evidence to make informeddecisions, check and improve health care quality and health care systems. Interpretation should no longer be guided just by statistical significance, but by a critical interpretation of what constitute a clinically relevant treatment effect. This implies a good understanding of changes in …

Efficacy of a digital lifestyle intervention on health-related QUAlity of life in non-small cell LUng CAncer survivors following inpatient rehabilitation: protocol of the …

Authors

Manuel Weber,Anja Maria Raab,Kai-Uwe Schmitt,Gilbert Büsching,Thimo Marcin,Marc Spielmanns,Milo Alan Puhan,Anja Frei

Journal

BMJ open

Published Date

2024/3/1

IntroductionNon-small cell lung cancer (NSCLC) survivors suffer from impaired physical and psychological functioning and reduced health-related quality of life (HRQoL) that persist after active treatment ends. Sustaining rehabilitation benefits, promoting a healthy lifestyle and facilitating self-management at home require a multifaceted aftercare programme. We aim to investigate the effect of a 12-week digital lifestyle intervention on HRQoL and lifestyle-related outcomes in NSCLC survivors after completion of inpatient rehabilitation.Methods and analysisQUAlity of life in LUng CAncer Survivors (QUALUCA) is a multicentre randomised controlled trial that follows a hybrid type 1 design. We randomly allocate participants in a 1:1 ratio to the intervention group (digital lifestyle intervention) or the control group (standard care) using block randomisation stratified by tumour stage and study site. Four accredited Swiss …

A discrete choice experiment on price and flavour effects on the appeal of nicotine products: a pilot study among young adults in Switzerland

Authors

Larissa Merz,Milo A Puhan,Miquel Serra-Burriel

Journal

Swiss Medical Weekly

Published Date

2024

AIMS: To explore the effects of prices and flavour availability on the appeal of different tobacco and nicotine products, including conventional cigarettes, Electronic Nicotine Delivery Systems (ENDS) and Heated Tobacco Systems (HTS) among an adult population in Switzerland.METHODS: We performed a Discrete Choice Experiment among a group of Swiss aged≥ 18 years via the online recruiting platform Prolific in a convenience sample. Our sample included both non-smokers and smokers. We used a within-subject, alternative-specific block design in a series of choice sets including different smoking products. We fixed the attributes of nicotine content (high or medium) and harmfulness (in years of life lost) for each product. Attributes of interest included price (ranging from CHF 5 to 25 in increments of 5) and flavour (fruity/menthol vs none/tobacco flavour). We performed a conditional logistic regression on the attributes’ influence on the appeal of cigarettes, ENDS and HTS.RESULTS: A total of 108 out of 153 participants (n= 25 smokers and n= 83 non-smokers, completion rate= 71%) successfully completed our pilot survey experiment. We found that, in general, increasing the price of combustible cigarettes, ENDS and HTS by one standard deviation (around CHF 7) reduced their appeal by approximately 66%(relative risk [RR]: 0.34; 95% CI: 0.28–0.42). Unflavoured alternative nicotine products were found to be less appealing than flavoured products, especially for non-smokers, with a 86% decrease in appeal (RR: 0.14; 95% CI: 0.13–0.16). For non-smokers, an increase in price by one standard deviation was associated with a decrease in …

Emerging Health Care Leaders: Lessons From a Novel Leadership and Community-Building Program

Authors

Andrea Martani,Agne Ulyte,Dominik Menges,Emily Reeves,Milo A Puhan,Rolf Heusser

Published Date

2024/4/4

BackgroundAlthough there are guidelines and ideas on how to improve public health education, translating innovative approaches into actual training programs remains challenging. In this article, we provide an overview of some initiatives that tried to put this into action in different parts of the world, and present the Emerging Health Care Leader (EHCL), a novel training program developed in Switzerland.Policy Options and RecommendationsLooking at the experience of the EHCL, we propose policymakers and other interested stakeholders who wish to help reform public health education to support these initiatives not only through funding, but by valuing them through the integration of early career healthcare leaders in projects where their developing expertise can be practically applied.ConclusionBy openly sharing the experiences, strengths, weaknesses, and lessons learned with the EHCL program, we aim to foster a transparent debate on how novel training programs in public health can be organised.

Experts vs. Machine Comparison of Machine Learning to Expert-Informed Prediction of Outcome After Major Liver Surgery

Authors

Roxane D Staiger,Tarun Mehra,Sarah R Haile,Anja Domenghino,Christoph Kuemmerli,Fariba Abbassi,Damian Kozbur,Philipp Dutkowski,Milo A Puhan,Pierre-Alain Clavien

Journal

HPB

Published Date

2024/2/13

BackgroundMachine learning (ML) has been successfully implemented for classification tasks (e.g., cancer diagnosis). ML performance for more challenging predictions is largely unexplored. This study’s objective was to compare machine learning vs. expert-informed predictions for surgical outcome in patients undergoing major liver surgery.MethodsSingle tertiary center data on preoperative parameters and postoperative complications for elective hepatic surgery patients were included (2008-2021). Expert-informed prediction models were established on 14 parameters identified by two expert liver surgeons to impact on postoperative outcome. ML models used all available preoperative patient variables (n=62). Model performance was compared for predicting 3-month postoperative overall morbidity. Temporal validation and additional analysis in major liver resection patients were conducted.Results891 patients …

See List of Professors in Milo Puhan University(Universität Zürich)

Milo Puhan FAQs

What is Milo Puhan's h-index at Universität Zürich?

The h-index of Milo Puhan has been 68 since 2020 and 91 in total.

What are Milo Puhan's top articles?

The articles with the titles of

Swiss chiropractic cohort (Swiss ChiCo) pilot study: feasibility for a musculoskeletal cohort study conducted within a nationwide practice-based research network

Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post–COVID-19 Syndrome

A guide for a student-led doctoral-level qualitative methods short course in epidemiology: faculty and student perspectives

Lung Cancer in Switzerland

What gets measured gets managed: A scoping review of musculoskeletal research conducted within practice-based research networks

Global benchmarks in primary robotic bariatric surgery redefine quality standards for Roux-en-Y gastric bypass and sleeve gastrectomy

Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter

A New Model for Ranking Schools of Public Health: The Public Health Academic Ranking

...

are the top articles of Milo Puhan at Universität Zürich.

What are Milo Puhan's research interests?

The research interests of Milo Puhan are: Epidemiologic methods, chronic diseases, multimorbidity, prevention, benefit harm assessment

What is Milo Puhan's total number of citations?

Milo Puhan has 42,135 citations in total.

What are the co-authors of Milo Puhan?

The co-authors of Milo Puhan are Gordon Guyatt, Alvar Agusti, Robert Wise, Kay Dickersin, Cynthia Boyd, Philipp Dutkowski.

    Co-Authors

    H-index: 296
    Gordon Guyatt

    Gordon Guyatt

    McMaster University

    H-index: 129
    Alvar Agusti

    Alvar Agusti

    Universidad de Barcelona

    H-index: 128
    Robert Wise

    Robert Wise

    Johns Hopkins University

    H-index: 81
    Kay Dickersin

    Kay Dickersin

    Johns Hopkins University

    H-index: 75
    Cynthia Boyd

    Cynthia Boyd

    Johns Hopkins University

    H-index: 56
    Philipp Dutkowski

    Philipp Dutkowski

    Universität Zürich

    academic-engine

    Useful Links